Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dysmenorrhea | 19 | 2023 | 49 | 8.910 |
Why?
|
| Chronic Pain | 9 | 2023 | 145 | 3.710 |
Why?
|
| Pelvic Pain | 12 | 2023 | 80 | 3.450 |
Why?
|
| Cystitis, Interstitial | 7 | 2021 | 53 | 3.340 |
Why?
|
| Pain Measurement | 11 | 2023 | 321 | 1.830 |
Why?
|
| Naproxen | 3 | 2021 | 13 | 1.700 |
Why?
|
| Urinary Bladder | 7 | 2023 | 245 | 1.530 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2023 | 45 | 1.310 |
Why?
|
| Uterus | 4 | 2021 | 215 | 1.270 |
Why?
|
| Visceral Pain | 2 | 2018 | 6 | 1.250 |
Why?
|
| Pain Threshold | 8 | 2022 | 58 | 1.240 |
Why?
|
| Dyspareunia | 2 | 2019 | 19 | 1.170 |
Why?
|
| Raphe Nuclei | 4 | 2012 | 37 | 1.150 |
Why?
|
| Hyperalgesia | 3 | 2021 | 16 | 0.920 |
Why?
|
| Oxytocin | 2 | 2020 | 71 | 0.820 |
Why?
|
| Morphine | 3 | 2012 | 130 | 0.800 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2022 | 243 | 0.730 |
Why?
|
| Dysuria | 1 | 2019 | 8 | 0.730 |
Why?
|
| Female | 26 | 2023 | 44561 | 0.710 |
Why?
|
| Muscle Contraction | 2 | 2018 | 284 | 0.700 |
Why?
|
| Constipation | 1 | 2019 | 63 | 0.680 |
Why?
|
| Sleep | 5 | 2012 | 444 | 0.680 |
Why?
|
| Pain, Referred | 1 | 2018 | 2 | 0.650 |
Why?
|
| Abdominal Muscles | 1 | 2018 | 19 | 0.650 |
Why?
|
| Pelvic Floor | 2 | 2017 | 84 | 0.650 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2018 | 4 | 0.640 |
Why?
|
| Muscle Cramp | 1 | 2018 | 5 | 0.640 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2017 | 18 | 0.610 |
Why?
|
| Uterine Contraction | 1 | 2017 | 9 | 0.610 |
Why?
|
| Platelet Activating Factor | 1 | 2017 | 53 | 0.600 |
Why?
|
| Pain Perception | 2 | 2018 | 18 | 0.590 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 1618 | 0.590 |
Why?
|
| Drug Resistance | 1 | 2017 | 256 | 0.570 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 115 | 0.560 |
Why?
|
| Nociceptive Pain | 1 | 2015 | 3 | 0.540 |
Why?
|
| Young Adult | 10 | 2022 | 5976 | 0.540 |
Why?
|
| Electromyography | 6 | 2018 | 184 | 0.510 |
Why?
|
| Adult | 13 | 2023 | 25647 | 0.510 |
Why?
|
| Analgesics, Opioid | 4 | 2021 | 413 | 0.470 |
Why?
|
| Humans | 26 | 2023 | 86648 | 0.460 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 3 | 2009 | 22 | 0.450 |
Why?
|
| Hypoxia | 1 | 2017 | 642 | 0.410 |
Why?
|
| Electroencephalography | 5 | 2010 | 709 | 0.400 |
Why?
|
| Fear | 2 | 2007 | 78 | 0.350 |
Why?
|
| Homeostasis | 3 | 2009 | 410 | 0.350 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 108 | 0.350 |
Why?
|
| Biological Clocks | 1 | 2010 | 74 | 0.340 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 2502 | 0.340 |
Why?
|
| Cardiovascular System | 1 | 2009 | 71 | 0.340 |
Why?
|
| Respiratory System | 1 | 2009 | 116 | 0.330 |
Why?
|
| Thalamus | 1 | 2010 | 132 | 0.320 |
Why?
|
| Wakefulness | 4 | 2012 | 134 | 0.320 |
Why?
|
| Neurons | 4 | 2012 | 1547 | 0.310 |
Why?
|
| Nociceptors | 1 | 2007 | 29 | 0.310 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 584 | 0.310 |
Why?
|
| Prospective Studies | 3 | 2023 | 4212 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 7 | 2012 | 3111 | 0.290 |
Why?
|
| Case-Control Studies | 3 | 2019 | 1809 | 0.240 |
Why?
|
| Mice | 9 | 2017 | 11439 | 0.240 |
Why?
|
| Animals | 11 | 2021 | 26704 | 0.220 |
Why?
|
| Analgesics | 2 | 2020 | 118 | 0.200 |
Why?
|
| Hot Temperature | 3 | 2012 | 206 | 0.190 |
Why?
|
| Rats | 4 | 2012 | 4002 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1804 | 0.180 |
Why?
|
| Comorbidity | 2 | 2022 | 944 | 0.180 |
Why?
|
| Heart Rate | 3 | 2019 | 493 | 0.170 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2021 | 139 | 0.170 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 56 | 0.170 |
Why?
|
| Microinjections | 2 | 2009 | 70 | 0.170 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 164 | 0.160 |
Why?
|
| Risk Factors | 2 | 2023 | 5416 | 0.160 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2018 | 40 | 0.160 |
Why?
|
| Menstruation | 1 | 2018 | 30 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2020 | 840 | 0.160 |
Why?
|
| Parasympatholytics | 1 | 2017 | 18 | 0.160 |
Why?
|
| Receptors, Oxytocin | 1 | 2017 | 10 | 0.160 |
Why?
|
| Sildenafil Citrate | 1 | 2017 | 23 | 0.150 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2017 | 18 | 0.150 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 28 | 0.150 |
Why?
|
| Dinoprost | 1 | 2017 | 26 | 0.150 |
Why?
|
| Denervation | 1 | 2017 | 34 | 0.150 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2017 | 29 | 0.150 |
Why?
|
| Sleep, REM | 3 | 2007 | 50 | 0.150 |
Why?
|
| Ablation Techniques | 1 | 2017 | 34 | 0.150 |
Why?
|
| Pharmacogenomic Variants | 1 | 2017 | 41 | 0.150 |
Why?
|
| Diuresis | 1 | 2017 | 29 | 0.150 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2017 | 103 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2009 | 1221 | 0.150 |
Why?
|
| Complementary Therapies | 1 | 2017 | 54 | 0.150 |
Why?
|
| Physical Examination | 2 | 2015 | 149 | 0.150 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 152 | 0.140 |
Why?
|
| Perfusion | 1 | 2017 | 203 | 0.140 |
Why?
|
| Seasons | 1 | 2018 | 223 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 159 | 0.140 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 203 | 0.140 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1824 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2023 | 2763 | 0.140 |
Why?
|
| Pressure | 1 | 2017 | 165 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 308 | 0.140 |
Why?
|
| Anxiety | 1 | 2018 | 286 | 0.140 |
Why?
|
| Medication Adherence | 1 | 2017 | 129 | 0.140 |
Why?
|
| Palpation | 1 | 2015 | 18 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 596 | 0.130 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 185 | 0.130 |
Why?
|
| Pelvic Floor Disorders | 1 | 2015 | 55 | 0.130 |
Why?
|
| Phenotype | 2 | 2019 | 2389 | 0.120 |
Why?
|
| Depression | 1 | 2018 | 472 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 999 | 0.120 |
Why?
|
| Sleep Deprivation | 3 | 2010 | 137 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1944 | 0.110 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 69 | 0.110 |
Why?
|
| Male | 8 | 2012 | 40990 | 0.100 |
Why?
|
| Pain | 2 | 2021 | 390 | 0.100 |
Why?
|
| Neuralgia | 1 | 2011 | 28 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2013 | 692 | 0.100 |
Why?
|
| Species Specificity | 1 | 2012 | 678 | 0.100 |
Why?
|
| Analgesia | 1 | 2011 | 57 | 0.090 |
Why?
|
| Anesthesia | 1 | 2012 | 163 | 0.090 |
Why?
|
| Physical Stimulation | 2 | 2007 | 70 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2010 | 2 | 0.090 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2010 | 25 | 0.090 |
Why?
|
| Sleep Stages | 1 | 2010 | 45 | 0.090 |
Why?
|
| Arrhythmia, Sinus | 1 | 2009 | 7 | 0.090 |
Why?
|
| Electrophysiology | 2 | 2007 | 401 | 0.090 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 66 | 0.090 |
Why?
|
| Bradycardia | 1 | 2009 | 39 | 0.090 |
Why?
|
| Theta Rhythm | 2 | 2007 | 27 | 0.090 |
Why?
|
| Adolescent | 2 | 2022 | 8981 | 0.090 |
Why?
|
| Motor Activity | 2 | 2009 | 327 | 0.090 |
Why?
|
| Hippocampus | 2 | 2006 | 442 | 0.080 |
Why?
|
| Action Potentials | 1 | 2012 | 573 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2019 | 1146 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2010 | 308 | 0.080 |
Why?
|
| Respiratory Insufficiency | 1 | 2009 | 150 | 0.080 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 148 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 187 | 0.080 |
Why?
|
| Receptors, Opioid, mu | 1 | 2007 | 45 | 0.080 |
Why?
|
| Electroshock | 1 | 2007 | 17 | 0.080 |
Why?
|
| Delta Rhythm | 1 | 2007 | 19 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 303 | 0.070 |
Why?
|
| Respiratory Mechanics | 1 | 2007 | 102 | 0.070 |
Why?
|
| Polysomnography | 1 | 2007 | 151 | 0.070 |
Why?
|
| Conditioning, Classical | 1 | 2006 | 35 | 0.070 |
Why?
|
| Association Learning | 1 | 2006 | 34 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 1557 | 0.070 |
Why?
|
| Amygdala | 1 | 2006 | 84 | 0.070 |
Why?
|
| Gene Expression | 1 | 2010 | 1286 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 297 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2007 | 478 | 0.060 |
Why?
|
| Memory | 1 | 2007 | 225 | 0.060 |
Why?
|
| Sympathetic Nervous System | 1 | 2004 | 106 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 66 | 0.060 |
Why?
|
| Skin | 1 | 2006 | 554 | 0.060 |
Why?
|
| Middle Aged | 2 | 2021 | 25026 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2243 | 0.050 |
Why?
|
| Arousal | 1 | 2003 | 170 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2704 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 94 | 0.050 |
Why?
|
| Urination | 1 | 2019 | 37 | 0.040 |
Why?
|
| Kindling, Neurologic | 1 | 1998 | 2 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 1998 | 32 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2021 | 768 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1239 | 0.040 |
Why?
|
| Epilepsy | 1 | 1998 | 397 | 0.030 |
Why?
|
| Nerve Block | 1 | 2011 | 50 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 85 | 0.020 |
Why?
|
| Child | 1 | 2022 | 6928 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1991 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 663 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 8475 | 0.020 |
Why?
|
| Posterior Horn Cells | 1 | 2006 | 8 | 0.020 |
Why?
|
| Muscimol | 1 | 2006 | 18 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2006 | 20 | 0.020 |
Why?
|
| Microelectrodes | 1 | 2006 | 81 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2006 | 16 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2006 | 50 | 0.020 |
Why?
|
| Rectum | 1 | 2006 | 146 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2006 | 347 | 0.020 |
Why?
|
| Catheterization | 1 | 2006 | 232 | 0.020 |
Why?
|
| Serotonin | 1 | 2006 | 219 | 0.020 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2004 | 6 | 0.020 |
Why?
|
| Cues | 1 | 2006 | 175 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2004 | 7 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2004 | 34 | 0.020 |
Why?
|
| Epinephrine | 1 | 2004 | 84 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2004 | 167 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2006 | 373 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 231 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1387 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 1853 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1998 | 46 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 1998 | 97 | 0.010 |
Why?
|
| Models, Neurological | 1 | 1998 | 405 | 0.010 |
Why?
|
| Computer Simulation | 1 | 1998 | 1079 | 0.010 |
Why?
|